Copyright Reports & Markets. All rights reserved.

Global Nucleic Acid-based Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Nucleic Acid-based Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Anti-Sense And Anti-Gene
    • 1.4.3 Short Inhibitory Sequences
    • 1.4.4 Gene Transfer Therapy
    • 1.4.5 Nucleoside Analogs
    • 1.4.6 Ribozymes
    • 1.4.7 Aptamers
  • 1.5 Market by Application
    • 1.5.1 Global Nucleic Acid-based Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Monogenetic Disorders
    • 1.5.3 Multi-Genetic Disorders
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Nucleic Acid-based Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Nucleic Acid-based Therapeutics Growth Trends by Regions
    • 2.2.1 Nucleic Acid-based Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Nucleic Acid-based Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Nucleic Acid-based Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Nucleic Acid-based Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Nucleic Acid-based Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Nucleic Acid-based Therapeutics Players by Market Size
    • 3.1.1 Global Top Nucleic Acid-based Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Nucleic Acid-based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Nucleic Acid-based Therapeutics Market Concentration Ratio
    • 3.2.1 Global Nucleic Acid-based Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Nucleic Acid-based Therapeutics Revenue in 2019
  • 3.3 Nucleic Acid-based Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Nucleic Acid-based Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Nucleic Acid-based Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Nucleic Acid-based Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Nucleic Acid-based Therapeutics Market Size (2015-2020)
  • 6.2 Nucleic Acid-based Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Nucleic Acid-based Therapeutics Market Size (2015-2020)
  • 7.2 Nucleic Acid-based Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Nucleic Acid-based Therapeutics Market Size (2015-2020)
  • 8.2 Nucleic Acid-based Therapeutics Key Players in China (2019-2020)
  • 8.3 China Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Nucleic Acid-based Therapeutics Market Size (2015-2020)
  • 9.2 Nucleic Acid-based Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Nucleic Acid-based Therapeutics Market Size (2015-2020)
  • 10.2 Nucleic Acid-based Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Nucleic Acid-based Therapeutics Market Size (2015-2020)
  • 11.2 Nucleic Acid-based Therapeutics Key Players in India (2019-2020)
  • 11.3 India Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Nucleic Acid-based Therapeutics Market Size (2015-2020)
  • 12.2 Nucleic Acid-based Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Wave Life Sciences
    • 13.1.1 Wave Life Sciences Company Details
    • 13.1.2 Wave Life Sciences Business Overview
    • 13.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Introduction
    • 13.1.4 Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2015-2020))
    • 13.1.5 Wave Life Sciences Recent Development
  • 13.2 Imugene
    • 13.2.1 Imugene Company Details
    • 13.2.2 Imugene Business Overview
    • 13.2.3 Imugene Nucleic Acid-based Therapeutics Introduction
    • 13.2.4 Imugene Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
    • 13.2.5 Imugene Recent Development
  • 13.3 Caperna
    • 13.3.1 Caperna Company Details
    • 13.3.2 Caperna Business Overview
    • 13.3.3 Caperna Nucleic Acid-based Therapeutics Introduction
    • 13.3.4 Caperna Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
    • 13.3.5 Caperna Recent Development
  • 13.4 Phylogica
    • 13.4.1 Phylogica Company Details
    • 13.4.2 Phylogica Business Overview
    • 13.4.3 Phylogica Nucleic Acid-based Therapeutics Introduction
    • 13.4.4 Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
    • 13.4.5 Phylogica Recent Development
  • 13.5 Protagonist Therapeutics
    • 13.5.1 Protagonist Therapeutics Company Details
    • 13.5.2 Protagonist Therapeutics Business Overview
    • 13.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Introduction
    • 13.5.4 Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
    • 13.5.5 Protagonist Therapeutics Recent Development
  • 13.6 Benitec Biopharma
    • 13.6.1 Benitec Biopharma Company Details
    • 13.6.2 Benitec Biopharma Business Overview
    • 13.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Introduction
    • 13.6.4 Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
    • 13.6.5 Benitec Biopharma Recent Development
  • 13.7 EGEN
    • 13.7.1 EGEN Company Details
    • 13.7.2 EGEN Business Overview
    • 13.7.3 EGEN Nucleic Acid-based Therapeutics Introduction
    • 13.7.4 EGEN Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
    • 13.7.5 EGEN Recent Development
  • 13.8 BioMedica
    • 13.8.1 BioMedica Company Details
    • 13.8.2 BioMedica Business Overview
    • 13.8.3 BioMedica Nucleic Acid-based Therapeutics Introduction
    • 13.8.4 BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
    • 13.8.5 BioMedica Recent Development
  • 13.9 Transgene
    • 13.9.1 Transgene Company Details
    • 13.9.2 Transgene Business Overview
    • 13.9.3 Transgene Nucleic Acid-based Therapeutics Introduction
    • 13.9.4 Transgene Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
    • 13.9.5 Transgene Recent Development
  • 13.10 Copernicus Therapeutics
    • 13.10.1 Copernicus Therapeutics Company Details
    • 13.10.2 Copernicus Therapeutics Business Overview
    • 13.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Introduction
    • 13.10.4 Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
    • 13.10.5 Copernicus Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Nucleic Acid-based Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nucleic Acid-based Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Wave Life Sciences
    Imugene
    Caperna
    Phylogica
    Protagonist Therapeutics
    Benitec Biopharma
    EGEN
    BioMedica
    Transgene
    Copernicus Therapeutics

    Market segment by Type, the product can be split into
    Anti-Sense And Anti-Gene
    Short Inhibitory Sequences
    Gene Transfer Therapy
    Nucleoside Analogs
    Ribozymes
    Aptamers
    Market segment by Application, split into
    Monogenetic Disorders
    Multi-Genetic Disorders

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now